本研究希望以amide oxime作為起始物進行環化反應來得到含氮雜環分子，研究初期希望以amide oxime與ethyl propiolate進行[3+2]環化加成反應得到五元環含氮雜環，卻意外的發現得到[3+3]環化加成產物2-phenylpyrimidin-4-one，但同時也發現，副反應ethyl propiolate進行[2+2+2]環化加成的反應速率大於[3+3]環化反應的速率，導致研究無法繼續下去。在篩選各種dipolarophic等同物後，發現使用enaminones化合物代替ethyl propiolate得到[3 + 2]環化產物imidazoles衍生物。接著進行後續反應條件優化探討，發現以O-substituteds amide oxime作為起始物與enaminones化合物在催化當量的鐵試劑條件下，成功合成出各種不同取代的imidazoles衍生物。

關鍵字：環化反應，含氮雜環，鐵試劑。

In this study, we used amide oxime as a starting material for cyclization reaction to obtain nitrogen-containing heterocyclic molecules. In the beginning of the study, we anticipated that the amide oxime and ethyl propiolate could undergo [3+2] cycloaddition to afford the five-membered ring nitrogen-containing heterocycls. However, we found that the reaction rate of the side reaction, [2+2+2] cycloaddition of ethyl propiolate to triethyl 1,3,5-benzenetricarboxylate, is greater than the rate of heterocycle formation, which surprisingly formed the six-membered heterocycle, 2-phenylpyrimidin-4-one, instead. After screening of various dipolarophile equivalents, we found that the use of the enaminones compound instead of ethyl propiolate gave the [3+2] cyclized product, and the cyclization adduct was found to be imidazole derivatives After the successful cyclization reaction, the subsequent optimization conditions were discussed. Finally, we found that using O-substituted amide oxime as the starting material reacted with enaminones in the catalytic amount of iron reagent can undergo [3+2] cycloaddition which successfully formed a variety of different substituted imidazole derivatives.

Keywords : O-substituted amide oxime, cycloaddition, enaminones, imidazole.

1. David T. Courtwright, Forces of Habit: Drugs and the Making of the Modern World, 1 ed. Harvard University Press: Cambridge, Mass., 2002.

2. Discovery and Development of Penicillin. American Chemical Society., 1999.

3. Vickery, Hubert Bradford; Leavenworth, Charles S., J. Biol. Chem. 1975, 78, 627–635.

4. S. Carmely, Y. Kashman. Tetrahedron Letters 1987, 28, 3003-3006.

5. A. Ahond, C. Poupat. Tetrahedron 1985, 41, 6019–6033.

6. N. Zidar, S. Montalvão, Ž. Hodnik, D. Nawrot, A. Žula. Mar. Drugs 2014, 12, 940–963.

7. T. Kuppens, W. Herrebout, B. Van Der Veken, D. Corens, A. De Groot, J. Doyon, G. Van Lommen, P. Bultinck. Chirality 2006, 18, 609–620.

8. M. van Leusen, J. Wildeman, H. Oldenzie. J. Org. Chem. 1977, 42, 1153-1159.

9. Br. Radzisewski. Eur. J. Inorg. Chem. 1882, 15, 2706–2708.

10. Von G. Kempterj, J. Spindlerh, H.-J. Fiebig, G. Sarodnick. J. Prakt. Chem. Bd. 1971, 313, 977–985.

11. S. Ahmad, K. Ngu, W. Combs, W.Shung, D. Weinstein, L. Wen, C. Bang-Chi, G. Chandrasena, R. Dorso, M. Kirby, S. Atwal. Bioorg. Med. Chem. Lett. 2004, 14, 177–180.

12. D. Carcache, I. Vranesic, J. Blanz, S. Desrayaud, M. Fendt, R. Glatthar. Med. Chem. Lett. 2011, 2, 58–62.

13. P. Bender, D. T. Hill, P. H. Offen, K. Razgaitis, P. Lavanchy, O. D. Stringer, B. M. Sutton, D. E. Griswold, M. DiMartino, D. T. Walz, I. Lantos, C. B. Laddo. J. Med. Chem. 1985, 28, 1169–1177.

14. T. Kumar, D. Verma, R. F. S. Menna-Barreto, W. O. Valença, Eufrânio N. da Silva Júnior, Irishi N. N. Namboothiri. Org. Biomol. Chem. 2015, 13, 1996–2000.

15. J.-M. Stutzmann, G. Andrees Bohme, A. Boireau, D. Damour, M. Williams Debono, A. Genevois-Borella, A. Imperato, Pa. Jimonet, J. Pratt, J. C. R. Randle, Y. Ribeill, M. Vuilhorgne, Se. Mignani. Bioorg. Med. Chem. Lett. 2000, 10, 1133–1137.

16. M. Vuilhorgne, J. Malpart, S. Mutti, S. Mignani. J. Heterocycl. Chem. 2003, 40, 159–162.

17. T. Canton, G. Andrees Bohme, A. Boireau, Franc¸ O. Bordier, S. Mignani, P. Jimonet, G. Jahn, M. Alavijeh, J. Stygall, S. Roberts, C. Brealey, M. Vuilhorgne, M.-W. Debono, S. Le Guern, M. Laville, D. Briet, M. Roux, J.-M. Stutzmann, J. Pratt. J. Pharmacol. Exp. Ther. 2001, 299, 314–322.

18. J. J. Baldwin, M. E. Christy, G. H. Denny, C. N. Habecker, M. B. Freedman, P. A. Lyle, G. S. Ponticello, S. L. Varga, D. M. Gross, C. S. Sweet. J. Med. Chem. 1986, 29, 1065–1080.

19. N. Kudo, S. Furuta, M. Taniguchi, T. Endo, and K. Sato. Chem. Pharm. Bull. 1999, 47, 857–868.

20. S. Liu, P. Nandha Premnath, J. K. Bolger, T. L. Perkins, L. O. Kirkland, G. Kontopidis, C. McInnes. J. Med. Chem. 2013, 56, 1573−1582.

21. R. C. Reid, M.-K. Yau, R. Singh, J. K. Hamidon, J. Lim, M. J. Stoermer, D. P. Fairlie. J. Med. Chem. 2014, 57, 8459−8470.

22. 林嘉祺, Facile Synthesis of Cyanamides and Unsymmetrical Urea via Tiemann Rearrangement, Master Dissertation, National Taiwan Normal University, 2011.
23. M. W. Partridge, H. A. Turner. J. Chem. Soc. 1958, 2086–2092.

24. Y. Yamamoto, T. Tsuritani, T. Mase. Tetrahedron Lett. 2008, 49, 876–878.

25. 謝宗翰,Synthetic Application of Amidoximes, Master Dissertation, National Taiwan Normal University, 2012.

26. Fang, J. Zhang, L. Cao, S. Shen, Y. Guo, Z. He, H. Hu. Tetrahedron 2016, 72, 2476–2480.